Pay in 4 interest-free payments of $5.45 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
Mechanism of Action: Triple Receptor Agonist Retatrutide is a synthetic peptide that activates three key metabolic receptors: GLP-1 (Glucagon-Like Peptide-1) Enhances insulin secretion, suppresses appetite, delays gastric emptying GIP (Glucose-Dependent Insulinotropic Polypeptide) Boosts insulin response, improves insulin sensitivity, may support lipid metabolism Glucagon Receptor (GCGR) Elevates energy expenditure, promotes fat oxidation, and may reduce liver fat This triple agonist profile delivers synergistic effects on glycemic control, fat loss, and metabolic health, making Retatrutide the most advanced incretin-based peptide in development
The D-amino-acid, reversed-sequence (DRI) design makes it highly resistant to protease degradation [2]
A 45-year-old woman with refractory ulcerative colitis achieved clinical remission after eight weeks of oral BPC-157 , confirmed by endoscopy
Unlike standard anti-aging ingredients that exfoliate or inflame the skin to stimulate renewal, GHK-Cu works by calming the skin, reducing inflammation, and restoring cellular communication
Understanding Spinal Arthritis and Its Primary Causes The spine contains more than 120 joints that allow bending and twisting movements
